Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK.
about
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationMet degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancersUpregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells.Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells.Silencing of c-Met by RNA interference inhibits the survival, proliferation, and invasion of nasopharyngeal carcinoma cells.Targeting MET by tyrosine kinase inhibitor suppresses growth and invasion of nasopharyngeal carcinoma cell lines.Identification of tetranectin as a potential biomarker for metastatic oral cancer.Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer.
P2860
Q24655473-B54BECFD-30E6-4597-873C-468D1E8327BBQ33654173-9F30094F-F776-4142-82FC-434B9C279F61Q34499040-A58C32D6-29E3-46EB-821E-67650C65B83CQ35067738-8713B47F-3904-4764-8997-EAC27F4450BFQ35232048-DB349C3E-C248-4C21-B073-13BAFC3E3A84Q35900248-6B99B2A6-62A0-485D-B5E2-EEA748303610Q35922535-217EEF7F-A79E-47C6-B7B7-5F88AE453609Q36164237-022C3B61-4486-4FE5-9102-B25B342FAC60Q38981340-46858D29-12EE-4B29-9A6D-C0ED958CCE7EQ39472980-610F0CC0-DE0C-4669-AFEF-692BFE6FE4B7Q39484796-0B8ED51A-BFE6-43AE-9BD8-3DC347DB67F8Q42409163-43BD02FF-191B-40B2-A154-B11EDDA1631DQ43506625-EEBA40B5-9B81-4D97-8CEF-830B593D6ABBQ51185572-9D7AD646-1044-4F26-B564-653DFCD70E78
P2860
Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Hepatocyte growth factor enhan ...... gh activation of PI3K and JNK.
@en
Hepatocyte growth factor enhan ...... gh activation of PI3K and JNK.
@nl
type
label
Hepatocyte growth factor enhan ...... gh activation of PI3K and JNK.
@en
Hepatocyte growth factor enhan ...... gh activation of PI3K and JNK.
@nl
prefLabel
Hepatocyte growth factor enhan ...... gh activation of PI3K and JNK.
@en
Hepatocyte growth factor enhan ...... gh activation of PI3K and JNK.
@nl
P2093
P2860
P1433
P1476
Hepatocyte growth factor enhan ...... ugh activation of PI3K and JNK
@en
P2093
Alice S T Wong
Carman K M Ip
Chris K C Wong
Hong Yan Zhou
Kai Fung Wan
Nai Ki Mak
P2860
P304
P356
10.1016/J.FEBSLET.2008.09.004
P407
P50
P577
2008-09-18T00:00:00Z